We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Computer-Simulation Used to Show Women in Their 40s have Lower Mammographic Tumor Detectability

By HospiMedica International staff writers
Posted on 24 Aug 2010
The reduced effectiveness of mammographic screening in women in their 40s is principally due to lower detectability instead of faster tumor growth rate, according to recent findings.

Mammography screening outcomes, gauged in terms of tumor size, lifetime gained, and mortality, have typically been poorer in women in their 40s than women in their 50s, somewhat because tumors of younger women are inclined to grow more quickly, so by the time they grow to a detectable size, they would have probably already been detected by a routine examination. More...
Younger women also tend to have denser breast tissue, which can hide tumors, reducing their detectability on mammograms.

To investigate which aspect--faster tumor growth rates, or reduced mammographic detectability--contributes to poorer mammography screening outcomes in younger women, Dr. Sylvia K. Plevritis, from the department of radiology at the Stanford University School of Medicine (Palo Alto, CA, USA), and colleagues, utilized a computer-simulated model to estimate the relative effect of biology and technology on mammograms of women in their 40s, compared to women in their 50s and 60s.

The researchers utilized the Breast Cancer Screening Simulator to create hypothetic screening situations whereby they could estimate the median tumor size detectable on a mammogram and the mean tumor growth rate in women aged 40-49 and 50-69. The researchers concluded from their simulation model that lowered mammographic tumor detectability accounted for 79% and faster tumor volume doubling time accounted for 21% of the poorer sensitivity in mammography screening among younger women, compared with older women.

The study's findings were published online July 27, 2010, in the Journal of the [U.S.] National Cancer Institute. The authors wrote, "The age-specific differences in mammographic tumor detection contribute more than age-specific differences in tumor growth rates to the lowered performance of mammography screening in younger women.”

One limitation of the analysis, according to the investigators, is that it did not take into account that low mammographic tumor detectability could be considered a breast cancer risk factor. They reported, "More research is needed to not only establish a better relationship between mammographic breast density and breast cancer risk but also understand the differences in tumor characteristics in dense vs. nondense breast tissue.”

Related Links:

Stanford University School of Medicine



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.